BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38424293)

  • 1. Cysteine protease inhibitor 1 promotes metastasis by mediating an oxidative phosphorylation/MEK/ERK axis in esophageal squamous carcinoma cancer.
    Zhang L; Chen X; Wang J; Chen M; Chen J; Zhuang W; Xia Y; Huang Z; Zheng Y; Huang Y
    Sci Rep; 2024 Feb; 14(1):4985. PubMed ID: 38424293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-942-5p inhibits tumor migration and invasion through targeting CST1 in esophageal squamous cell carcinoma.
    Zhang L; Yu S; Yin X; Tu M; Cai L; Zhang Y; Yu L; Zhang S; Pan X; Huang Y
    PLoS One; 2023; 18(2):e0277006. PubMed ID: 36848349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non‑coding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway.
    Yu X; Huang M; Yang G
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPI1-Mediated Upregulation of the
    Luo FF; Wang J; Zhang ZF; Lin ST; Huang TJ; Liu BQ; Fan ML; Peng LX; Zheng ST; Yang CF; Huang BJ
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):212. PubMed ID: 37796690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway.
    Nan P; Wang T; Li C; Li H; Wang J; Zhang J; Dou N; Zhan Q; Ma F; Wang H; Qian H
    Carcinogenesis; 2020 Sep; 41(9):1263-1272. PubMed ID: 31783401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA GK-IT1 promotes esophageal squamous cell carcinoma by regulating MAPK1 phosphorylation.
    Yang X; Zeng T; Liu Z; He W; Hu M; Tang T; Chen L; Xing L
    Cancer Med; 2022 Dec; 11(23):4555-4574. PubMed ID: 35608100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin.
    Jiang Y; Zhang J; Zhao J; Li Z; Chen H; Qiao Y; Chen X; Liu K; Dong Z
    BMC Cancer; 2019 Dec; 19(1):1264. PubMed ID: 31888532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of serum cystatin SN detection for diagnosis and poor prognosis of esophageal squamous cell carcinoma.
    Pi Y; Lin S; Ren X; Wang L; Song Y; Wu Z; Lai Y
    Front Oncol; 2024; 14():1337707. PubMed ID: 38414741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FBXW7 loss of function promotes esophageal squamous cell carcinoma progression via elevating MAP4 and ERK phosphorylation.
    Pan Y; Liu J; Gao Y; Guo Y; Wang C; Liang Z; Wu M; Qian Y; Li Y; Shen J; Lu C; Ma S
    J Exp Clin Cancer Res; 2023 Mar; 42(1):75. PubMed ID: 36991467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periplcymarin targets glycolysis and mitochondrial oxidative phosphorylation of esophageal squamous cell carcinoma: Implication in anti-cancer therapy.
    Han L; Xiang X; Fu Y; Wei S; Zhang C; Li L; Liu Y; Lv H; Shan B; Zhao L
    Phytomedicine; 2024 Jun; 128():155539. PubMed ID: 38522311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USP4 promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting TAK1.
    Zhang H; Han Y; Xiao W; Gao Y; Sui Z; Ren P; Meng F; Tang P; Yu Z
    Cell Death Dis; 2023 Nov; 14(11):730. PubMed ID: 37949874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
    Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANXA2 as a novel substrate of FBXW7 promoting esophageal squamous cell carcinoma via ERK phosphorylation.
    Li Z; Pan Y; Yao J; Gao Y; Qian Y; Zheng M; Ma S
    Biochem Biophys Res Commun; 2023 Mar; 649():93-100. PubMed ID: 36758484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting p21-activated kinase 1 inhibits growth and metastasis via Raf1/MEK1/ERK signaling in esophageal squamous cell carcinoma cells.
    Chen L; Bi S; Hou J; Zhao Z; Wang C; Xie S
    Cell Commun Signal; 2019 Apr; 17(1):31. PubMed ID: 30971268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking STAT3 signaling augments MEK/ERK inhibitor efficacy in esophageal squamous cell carcinoma.
    Zheng ZY; Chu MY; Lin W; Zheng YQ; Xu XE; Chen Y; Liao LD; Wu ZY; Wang SH; Li EM; Xu LY
    Cell Death Dis; 2022 May; 13(5):496. PubMed ID: 35614034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non‑coding RNA BANCR mediates esophageal squamous cell carcinoma progression by regulating the IGF1R/Raf/MEK/ERK pathway via miR‑338‑3p.
    Song W; Wang K; Yang X; Dai W; Fan Z
    Int J Mol Med; 2020 Oct; 46(4):1377-1388. PubMed ID: 32945416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCF7L2 and EGR1 synergistic activation of transcription of LCN2 via an ERK1/2-dependent pathway in esophageal squamous cell carcinoma cells.
    Zhao Y; Xia Q; Liu Y; Bai W; Yao Y; Ding J; Lin L; Xu Z; Cai Z; Wang S; Li E; Xu H; Wu B; Xu L; Du Z
    Cell Signal; 2019 Mar; 55():8-16. PubMed ID: 30557604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma.
    Shigeoka M; Urakawa N; Nishio M; Takase N; Utsunomiya S; Akiyama H; Kakeji Y; Komori T; Koma Y; Yokozaki H
    Cancer Med; 2015 Mar; 4(3):437-46. PubMed ID: 25620088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition.
    Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z
    Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.